Catalyst
Slingshot members are tracking this event:
Shire launches pediatric indication for immunodeficiency treatment HyQvia in Europe
- Source Link:
- https://www.shire.com/newsroom/2016/july/wzr2ca
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
SHPG |
|
|
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jul 21, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Hyqvia, Subcutaneous Ig Treatment, Secondary Immunodeficiencies, Recombinant Human Hyaluronidase, Immunodeficiencies